Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
41,966,083
-
Total 13F shares
-
6,107,903
-
Share change
-
-2,412,181
-
Total reported value
-
$9,284,001
-
Price per share
-
$1.52
-
Number of holders
-
50
-
Value change
-
-$4,059,329
-
Number of buys
-
26
-
Number of sells
-
36
Institutional Holders of Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) as of Q2 2024
As of 30 Jun 2024,
Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,107,903 shares.
The largest 10 holders included
VANGUARD GROUP INC, TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, TPG GP A, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.